BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2903204)

  • 1. Effects of topically applied falintolol: a new beta-adrenergic antagonist for treatment of glaucoma.
    Himber J; Sallee VL; Andermann G; Bouzoubaa M; Leclerc G; De Santis L
    J Ocul Pharmacol; 1987; 3(2):111-20. PubMed ID: 2903204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic and systemic side effects of ocular beta-adrenergic antagonists in anesthetized dogs.
    Svec AL; Strosberg AM
    Invest Ophthalmol Vis Sci; 1986 Mar; 27(3):401-5. PubMed ID: 2869005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects.
    Nathanson JA
    Br J Pharmacol; 1984 Nov; 83(3):821-9. PubMed ID: 6150744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.
    Chiang CH; Ho JI; Chen JL
    J Ocul Pharmacol Ther; 1996; 12(4):471-80. PubMed ID: 8951683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro potential measurement, anaesthetic and antimicrobial effects as indicators of beta-blocker toxicity of the cornea.
    Himber J; Andermann G; Erhart M; Leclerc G; Bouzoubaa M
    Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):195-201. PubMed ID: 2862314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans.
    Kanno M; Araie M; Koibuchi H; Masuda K
    Br J Ophthalmol; 2000 Mar; 84(3):293-9. PubMed ID: 10684841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbit.
    Vareilles P; Silverstone D; Plazonnet B; Le Douarec JC; Sears ML; Stone CA
    Invest Ophthalmol Vis Sci; 1977 Nov; 16(11):987-96. PubMed ID: 21145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of falintolol II. Absorption, distribution and elimination from tissues and organs following ocular administration and intravenous injection of falintolol in albino rabbits.
    Andermann G; Guggenbuhl P; de Burlet G; Himber J
    Methods Find Exp Clin Pharmacol; 1989 Dec; 11(12):747-54. PubMed ID: 2576299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of timolol maleate gel-forming solution on intraocular pressure, pupil diameter, and heart rate in normal and glaucomatous cats.
    Kiland JA; Voss AM; McLellan GJ
    Vet Ophthalmol; 2016 Jul; 19 Suppl 1(Suppl 1):91-6. PubMed ID: 26991029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timolol maleate: side effects on healthy nonglaucomatous volunteers.
    Davidson J; Ribak J; Eckstein D; Barishak R
    Aviat Space Environ Med; 1983 Apr; 54(4):360-2. PubMed ID: 6133515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of D-timolol on intraocular pressure (IOP), beta blocking activity, and the dynamic changes of drug concentrations in aqueous humor.
    Zhao F; Ji XC; Zheng YZ
    J Ocul Pharmacol; 1989; 5(4):271-9. PubMed ID: 2576432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ophthalmic beta-blocking agents.
    Lesar TS
    Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of multiple doses of 4 and 6% timolol, and timolol combined with 2% pilocarpine in clinically normal beagles and beagles with glaucoma.
    Gelatt KN; Larocca RD; Gelatt JK; Strubbe DT; MacKay EO
    Am J Vet Res; 1995 Oct; 56(10):1325-31. PubMed ID: 8928950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.
    Zimmerman TJ; Kaufman HE
    Arch Ophthalmol; 1977 Apr; 95(4):601-4. PubMed ID: 322648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timolol. A new drug for management of chronic simple glaucoma.
    Radius RL; Diamond GR; Pollack IP; Langham ME
    Arch Ophthalmol; 1978 Jun; 96(6):1003-8. PubMed ID: 655936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beta-adrenergic blocking agents and the treatment of glaucoma.
    Zimmerman TJ; Boger WP
    Surv Ophthalmol; 1979; 23(6):347-62. PubMed ID: 37605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of timolol maleate on untreated contralateral eyes (author's transl)].
    Spinelli D; Montanari P; Vigasio F; Cormanni V
    J Fr Ophtalmol; 1982; 5(3):153-8. PubMed ID: 7096893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A complex interaction between topical verapamil and timolol on intraocular pressure in conscious rabbits.
    Santafé J; Martínez de Ibarreta MJ; Segarra J; Melena J; Garrido M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):198-204. PubMed ID: 8857598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of ocular drugs. 1. Timolol maleate.
    Kaufman HE
    Ophthalmology; 1980 Feb; 87(2):164-8. PubMed ID: 6104319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.